Giving new hope to patients.

May 8, 2015 | News, Events, Research & Innovation

When the late Paul Poth was diagnosed with a form of cancer so rare there was no treatment, he helped to launch a highly promising area of cancer research that is giving new hope to patients.” 

A great piece from a Massachusetts General Hospital newsletter on TargetCancer Foundation’s work with MGH that recently led to a new cholangiocarcinoma clinical trial.

Read the entire story here.

You can help support this clinical trial! Learn more.